152 related articles for article (PubMed ID: 17662321)
1. Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough?
Lynen L; Jacobs J; Colebunders R
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1059-60. PubMed ID: 17662321
[TBL] [Abstract][Full Text] [Related]
2. Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries.
Zachariah R; Harries AD; Luo C; Bachman G; Graham SM
Lancet Infect Dis; 2007 Oct; 7(10):686-93. PubMed ID: 17897611
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for fungal opportunistic infections prevention in persons infected with human immunodeficiency virus.
Popa LG; Popa MI; Zaharia A; Ocneanu M
Roum Arch Microbiol Immunol; 1999; 58(2):185-95. PubMed ID: 11845456
[TBL] [Abstract][Full Text] [Related]
4. Consensus on use of co-trimoxazole.
Trop Doct; 2001 Jul; 31(3):189-90. PubMed ID: 11444358
[No Abstract] [Full Text] [Related]
5. Cotrimoxazole prophylaxis in HIV-infected pregnant women: only a first step.
Heather Watts D; Mofenson LM
J Infect Dis; 2006 Dec; 194(11):1478-80. PubMed ID: 17083031
[No Abstract] [Full Text] [Related]
6. Co-trimoxazole-induced myopia in an HIV-positive patient.
Kamath S; Acharya N; Nithyanandam S
Int J STD AIDS; 2012 Jan; 23(1):71-2. PubMed ID: 22362698
[TBL] [Abstract][Full Text] [Related]
7. Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Ribera E; Fernandez-Sola A; Juste C; Rovira A; Romero FJ; Armadans-Gil L; Ruiz I; Ocaña I; Pahissa A
Clin Infect Dis; 1999 Dec; 29(6):1461-6. PubMed ID: 10585796
[TBL] [Abstract][Full Text] [Related]
8. A background and critical analysis of the treatment of pneumocystis carinii pneumonia (PCP) in HIV/AIDS.
Mitchell B
Aust Nurs J; 2007 Apr; 14(9):20-3. PubMed ID: 17441498
[No Abstract] [Full Text] [Related]
9. Opportunistic infections and HIV.
Ioannidis J; Wilkinson D
Clin Evid; 2002 Jun; (7):717-37. PubMed ID: 12230699
[No Abstract] [Full Text] [Related]
10. Co-trimoxazole prophylaxis in HIV: the evidence.
Young T; Oliphant CE; Araoyinbo I; Volmink J
S Afr Med J; 2008 Apr; 98(4):258-9. PubMed ID: 18637628
[No Abstract] [Full Text] [Related]
11. Cotrimoxazole prophylaxis for HIV-positive TB patients in developing countries.
Zachariah R; Massaquoi M
Trop Doct; 2006 Apr; 36(2):79-82. PubMed ID: 16611438
[TBL] [Abstract][Full Text] [Related]
12. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda.
Bikaako-Kajura W; Luyirika E; Purcell DW; Downing J; Kaharuza F; Mermin J; Malamba S; Bunnell R
AIDS Behav; 2006 Jul; 10(4 Suppl):S85-93. PubMed ID: 16791525
[TBL] [Abstract][Full Text] [Related]
13. Balancing individual benefit against public health risk: the impact of cotrimoxazole prophylaxis in HIV-infected patients on antimicrobial resistance.
Hamer DH; Gill CJ
Am J Trop Med Hyg; 2008 Sep; 79(3):299-300. PubMed ID: 18784218
[No Abstract] [Full Text] [Related]
14. Co-trimoxazole in HIV-1 infection.
Brindle R
Lancet; 1999 Jul; 354(9175):333-4; author reply 335. PubMed ID: 10440329
[No Abstract] [Full Text] [Related]
15. Co-trimoxazole in HIV-1 infection.
Hudson CP; Roach T
Lancet; 1999 Jul; 354(9175):333; author reply 335. PubMed ID: 10440328
[No Abstract] [Full Text] [Related]
16. Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa.
;
Afr Health Sci; 2001 Aug; 1(1):30-1. PubMed ID: 12833907
[No Abstract] [Full Text] [Related]
17. Co-trimoxazole in HIV-1 infection.
Boeree MJ; Harries AD; Zijlstra EE; Taylor TE; Molyneux ME
Lancet; 1999 Jul; 354(9175):334; author reply 335. PubMed ID: 10440330
[No Abstract] [Full Text] [Related]
18. Severe hyponatraemia and severe hyperkalaemia in an HIV positive patient who received high dose co-trimoxazole.
David LM; Ross J
Sex Transm Infect; 1998 Feb; 74(1):75-6. PubMed ID: 9634313
[No Abstract] [Full Text] [Related]
19. Cotrimoxazole prophylaxis for infants exposed to HIV infection.
Graham SM
Bull World Health Organ; 2004 Apr; 82(4):297-8. PubMed ID: 15259259
[No Abstract] [Full Text] [Related]
20. District-randomized phased implementation: strengthening the evidence base for cotrimoxazole for HIV-positive tuberculosis patients.
Godfrey-Faussett P
AIDS; 2003 May; 17(7):1079-81. PubMed ID: 12700460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
